Human pluripotent stem cell therapy for Huntington’s disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington’s disease: technical, immunological, and safety challenges
In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria
Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies
Jumping translocations of chromosome 1q are recurring chromosomal -aberrations in neural derivatives of pluripotent stem cells
